INTERNATIONAL PATENT: BETH ISRAEL DEACONESS MEDICAL CENTER, INC., THE REGENTS OF THE UNIVERSITY OF CALIFORNIA FILES APPLICATION FOR "AN INHIBITOR OF SOLUBLE EPOXIDE HYDROLASE FOR USE IN THE TREATMENT OF CANCER CACHEXIA"

GENEVA, Oct. 20 -- BETH ISRAEL DEACONESS MEDICAL CENTER, INC. (Technology Venture Office, BR2109 Brookline Ave.Boston, Massachusetts 02215), THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (1111 Franklin Street, 12th FloorOakland, California 94607) filed a patent application (PCT/US2025/023596) for "AN INHIBITOR OF SOLUBLE EPOXIDE HYDROLASE FOR USE IN THE TREATMENT OF CANCER CACHEXIA" on Apr 08, 2025. With publication no. WO/2025/217124, the details related to the patent application was published on Oct 16, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): PANIGRAHY, Dipak (c/o BIDMC Technology Ve...